Trulicity’s turn to show a cardiovascular benefit

Trulicity’s turn to show a cardiovascular benefit

Submitted by admin on September 4, 2018 - 5:04pm
Source: 
EP Vantage
News Tags: 
Trulicity
Eli Lilly
Headline: 
Trulicity’s turn to show a cardiovascular benefit
snippet: 
In the Rewind trial, whose readout is due by year-end, Trulicity needs to avert heart complications and show clean safety to keep up with other glucose-lowering drugs.

Do Not Allow Advertisers to Use My Personal information